Clinical Trials Directory

Trials / Completed

CompletedNCT00130039

Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II

Trial for Efficacy and Safety of Cilostazol on the Progression of Symptomatic Intracranial Stenosis Comparing Clopidogrel

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
457 (actual)
Sponsor
Asan Medical Center · Academic / Other
Sex
All
Age
35 Years
Healthy volunteers
Not accepted

Summary

This study will recruit 480 acute stroke patients with symptomatic intracranial stenosis (M1 segment of Middle cerebral artery (MCA) or basilar artery). They will be randomly assigned into cilostazol group or clopidogrel group. Every patients will take 100mg of aspirin a day additionally. The primary outcome variable of this study is Progression rate of symptomatic intracranial stenosis on magnetic resonance angiogram (MRA).

Detailed description

\[Goal\] To Reveal the Effect and Safety of Cilostazol Compared with Clopidogrel on the Prevention of the Progression of Symptomatic Intracranial Arterial Stenosis. \[Trial Design\] Double-Blind, Active-Controlled, Randomized, Multicenter Trial \[Participants\] Acute ischemic stroke patients with symptomatic intracranial arterial stenosis \[Methods\] * Double-Blind, Active-Controlled, Randomized, Multicenter Trial * Investigational product (Double Dummy Method): Cilostazol 200mg (100mg twice per day) versus clopidogrel 75mg * Concomitant medication: Aspirin 100 (75-150) mg per day * Medication Duration: 7 months \[Outcome Variables\] Primary Outcome Variable: * Progression rate of symptomatic intracranial arterial stenosis Secondary outcome variables: * The occurrence of new MRI (magnetic resonance image) lesion on follow-up MRI * Stroke events * Overall cardiovascular events: stroke, acute coronary syndrome, vascular death * Ipsilateral ischemic stroke rate * Fatal or major bleeding complications

Conditions

Interventions

TypeNameDescription
DRUGclopidogrelClopidogrel 75mg once a day plus placebo of cilostazol twice a day
DRUGCilostazolCilostazol 100mg twice a day plus placebo of clopidogrel once a day

Timeline

Start date
2005-08-01
Primary completion
2009-01-01
Completion
2009-01-01
First posted
2005-08-15
Last updated
2010-01-12
Results posted
2010-01-01

Locations

19 sites across 4 countries: Hong Kong, Philippines, South Korea, Thailand

Source: ClinicalTrials.gov record NCT00130039. Inclusion in this directory is not an endorsement.